|
Title
|
Published
|
Price
|
|
Clinical Research Outsourcing and India
By: Scope eKnowledge Center Ltd.
A Clinical research (CR) organization is one that manages a research or an investigation to assess and/or verify the clinical, pharmacological or other pharmacodynamic effects, safety and/or efficacy and adverse reactions of an investigational product.
|
more...
Search inside this report
|
6/1/2006
|
$1,000.00
|
|
Watson Pharmaceuticals Inc.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Vivus Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
United Therapeutics Corporation
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Teva Pharmaceuticals Industries Ltd.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Savient Pharmaceuticals Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Pharmaceutical Product Development, Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Pacific Health Systems Inc.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Orphan Medical Inc.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Kendle International Inc.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Inkine Pharmaceutical Company Inc.
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Icon Plc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Hi-Tech Pharmacal, Co. Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Cytogen Corporation
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
C V Therapeutics Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Curative Health Services Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Columbia Laboratories Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
CollaGenex Pharmaceuticals Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Barr Pharmaceuticals Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Arena Pharmaceuticals Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Acambis PLC
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
9/1/2004
|
$375.00
|
|
Wyeth
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
8/1/2004
|
$375.00
|
|
Vistacare Inc
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
8/1/2004
|
$375.00
|
|
The Quigley Corporation
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
8/1/2004
|
$375.00
|
|
Serono SA
By: Scope eKnowledge Center Ltd.
Scope’s PharmaTrack offering is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value
|
more...
Search inside this report
|
8/1/2004
|
$375.00
|
|
Title
|
Published
|
Price
|